首页> 外文期刊>The American heart journal >Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes ( SMART-DATE) prospective multicenter randomized trial
【24h】

Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes ( SMART-DATE) prospective multicenter randomized trial

机译:急性冠状动脉综合征患者经皮冠状动脉干预后6个月持续时间持续时间:理论与设计急性冠状动脉患者急性冠状动脉经皮冠状动脉介入后6个月持续时间急性血管成形术研究团队 - 安全性 综合征(智能日期)预期多中心随机试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background and rationale Dual antiplatelet therapy (DAPT) is a fundamental treatment that optimizes clinical outcomes after percutaneous coronary intervention, especially in patients with acute coronary syndrome (ACS). Although current international guidelines recommend DAPT for at least 12 months after implantation of a drug-eluting stent in patients with ACS, these recommendations are not based on randomized controlled trials dedicated to ACS population.
机译:背景和基本原理双重抗血小板治疗(DAPT)是优化经皮冠状动脉介入治疗后临床疗效的基础治疗,尤其是在急性冠状动脉综合征(ACS)患者中。尽管目前的国际指南建议ACS患者在植入药物洗脱支架后至少12个月进行DAPT,但这些建议并不是基于专门针对ACS人群的随机对照试验。

著录项

  • 来源
    《The American heart journal》 |2016年第2016期|共8页
  • 作者单位

    Sungkyunkwan Univ Sch Med Dept Med Samsung Med Ctr Div Cardiol Seoul South Korea;

    Myongji Hosp Dept Internal Med Div Cardiol Gyenggi Do South Korea;

    Sungkyunkwan Univ Sch Med Dept Med Samsung Med Ctr Div Cardiol Seoul South Korea;

    Sungkyunkwan Univ Sch Med Dept Med Samsung Med Ctr Div Cardiol Seoul South Korea;

    Sungkyunkwan Univ Sch Med Dept Med Samsung Med Ctr Div Cardiol Seoul South Korea;

    Sungkyunkwan Univ Sch Med Samsung Changwon Hosp Dept Cardiol Chang Won South Korea;

    Daegu Catholic Univ Med Ctr Daegu South Korea;

    Inje Univ Ilsan Paik Hosp Dept Med Goyang South Korea;

    Seoul Natl Univ Boramae Med Ctr Ctr Cardiovasc Seoul South Korea;

    Sungkyunkwan Univ Sch Med Dept Med Samsung Med Ctr Div Cardiol Seoul South Korea;

    Sungkyunkwan Univ Sch Med Dept Med Samsung Med Ctr Div Cardiol Seoul South Korea;

    Sungkyunkwan Univ Sch Med Dept Med Samsung Med Ctr Div Cardiol Seoul South Korea;

    Sungkyunkwan Univ Sch Med Dept Med Samsung Med Ctr Div Cardiol Seoul South Korea;

    Sungkyunkwan Univ Sch Med Dept Med Samsung Med Ctr Div Cardiol Seoul South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 心脏、血管(循环系)疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号